IGF-1 LR3

IGF-1 LR3 exerts its biochemical effects primarily through high-affinity binding to the IGF-1 receptor (IGF-1R), a transmembrane receptor tyrosine kinase. Ligand binding induces receptor homodimerization and transphosphorylation of intracellular tyrosine residues, creating docking sites for adaptor proteins including insulin receptor substrate-1 (IRS-1) and Shc. This initiates two principal downstream cascades: the PI3K/AKT/mTOR pathway, which promotes anabolic processes such as protein synthesis and inhibition of apoptosis, and the RAS/MAPK/ERK pathway, which drives mitogenic and pro-proliferative transcriptional programs.

The structural modification distinguishing IGF-1 LR3 from native IGF-1—specifically the Arg³ substitution and N-terminal extension—reduces affinity for insulin-like growth factor binding proteins (IGFBPs 1–6) by approximately 1,000-fold, effectively preventing sequestration. In serum-containing culture environments where endogenous IGFBPs are present, this property allows IGF-1 LR3 to maintain prolonged receptor engagement. The compound also demonstrates low but measurable cross-reactivity with the insulin receptor (IR), a relevant consideration in experimental designs examining metabolic pathway crosstalk or in cell lines with high IR expression levels.

IGF-1 LR3 is employed across multiple in vitro and preclinical research contexts to interrogate IGF-1R-dependent signaling, anabolic pathway regulation, and growth factor biology. Representative research application areas include:

• Cell Proliferation and Growth Assays: Used to stimulate and quantify IGF-1R-mediated mitogenic responses in a range of mammalian cell lines, enabling dose-response characterization under IGFBP-free conditions.
• Apoptosis and Cell Survival Studies: Applied to investigate the anti-apoptotic properties of the PI3K/AKT axis in serum-starved or stress-induced in vitro models.
• Skeletal Muscle Cell Differentiation Research: Utilized in myoblast and satellite cell culture systems to study hypertrophic signaling, myotube formation, and protein synthesis regulation.
• Receptor Signaling Pathway Mapping: Serves as a reference agonist in phosphoproteomics and Western blot-based studies delineating IGF-1R versus IR pathway contributions.
• Serum-Free Culture Media Optimization: Incorporated into defined, serum-free media formulations to support cell expansion while minimizing undefined biological variables.
• Metabolic and Glucose Uptake Studies: Employed to probe insulin/IGF-1 receptor crosstalk in adipocyte, hepatocyte, or pancreatic beta-cell in vitro models relevant to metabolic pathway research.